Li R, Feng D, Han S, Zhai X, Yu X, Fu Y
Mater Today Bio. 2023; 22:100783.
PMID: 37701130
PMC: 10494263.
DOI: 10.1016/j.mtbio.2023.100783.
Inoue K, Qin Y, Xia Y, Han J, Yuan R, Sun J
Elife. 2023; 12.
PMID: 36779851
PMC: 10005769.
DOI: 10.7554/eLife.82118.
Yang G, Zhou S, He H, Shen Z, Liu Y, Hu J
Front Pharmacol. 2022; 13:1022627.
PMID: 36523490
PMC: 9744761.
DOI: 10.3389/fphar.2022.1022627.
Sun H, Tan J, Chen H, Wu N, Su B
Front Immunol. 2022; 13:1057932.
PMID: 36405734
PMC: 9669707.
DOI: 10.3389/fimmu.2022.1057932.
Tang J, Frey J, Wilson C, Moncada-Pazos A, Levet C, Freeman M
Mol Cell Biol. 2018; 38(17).
PMID: 29891514
PMC: 6094052.
DOI: 10.1128/MCB.00103-18.
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
Zins K, Heller G, Mayerhofer M, Schreiber M, Abraham D
Oncotarget. 2018; 9(33):23126-23148.
PMID: 29796177
PMC: 5955405.
DOI: 10.18632/oncotarget.25226.
A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.
Lau K, Sheng M
Arch Biochem Biophys. 2018; 650:30-38.
PMID: 29763590
PMC: 5985224.
DOI: 10.1016/j.abb.2018.05.014.
Does niche competition determine the origin of tissue-resident macrophages?.
Guilliams M, Scott C
Nat Rev Immunol. 2017; 17(7):451-460.
PMID: 28461703
DOI: 10.1038/nri.2017.42.
Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N, Fernandez M, Giardino L, Calza L
J Neuroinflammation. 2016; 13(1):291.
PMID: 27846891
PMC: 5111339.
DOI: 10.1186/s12974-016-0757-6.
Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages.
Rex J, Albrecht U, Ehlting C, Thomas M, Zanger U, Sawodny O
PLoS Comput Biol. 2016; 12(7):e1005018.
PMID: 27464342
PMC: 4963125.
DOI: 10.1371/journal.pcbi.1005018.
FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.
Qian B, Zhang H, Li J, He T, Yeo E, Soong D
J Exp Med. 2015; 212(9):1433-48.
PMID: 26261265
PMC: 4548055.
DOI: 10.1084/jem.20141555.
Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21.
Caescu C, Guo X, Tesfa L, Bhagat T, Verma A, Zheng D
Blood. 2015; 125(8):e1-13.
PMID: 25573988
PMC: 4335087.
DOI: 10.1182/blood-2014-10-608000.
Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation.
Kant S, Kumar A, Singh S
PLoS One. 2013; 8(12):e82396.
PMID: 24349275
PMC: 3857782.
DOI: 10.1371/journal.pone.0082396.
Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.
Menke J, Kriegsmann J, Schimanski C, Schwartz M, Schwarting A, Kelley V
Cancer Res. 2011; 72(1):187-200.
PMID: 22052465
PMC: 3251714.
DOI: 10.1158/0008-5472.CAN-11-1232.
Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development.
Lee A, Mao Y, Penninger J, Yu S
Mol Cell Biol. 2011; 31(22):4563-81.
PMID: 21930791
PMC: 3209260.
DOI: 10.1128/MCB.05706-11.
Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.
Gueller S, Goodridge H, Niebuhr B, Xing H, Koren-Michowitz M, Serve H
J Leukoc Biol. 2010; 88(4):699-706.
PMID: 20571037
PMC: 3218676.
DOI: 10.1189/jlb.0309185.
Osteoimmunology: interactions of the bone and immune system.
Lorenzo J, Horowitz M, Choi Y
Endocr Rev. 2008; 29(4):403-40.
PMID: 18451259
PMC: 2528852.
DOI: 10.1210/er.2007-0038.
Improvement of the breaking strength of wound by combined treatment with recombinant human G-CSF, recombinant human M-CSF, and a TGF-beta1 receptor kinase inhibitor in rat skin.
Sugiyama K, Ishii G, Ochiai A, Esumi H
Cancer Sci. 2008; 99(5):1021-8.
PMID: 18380792
PMC: 11159857.
DOI: 10.1111/j.1349-7006.2008.00761.x.
Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis.
Ide H, Hatake K, Terado Y, Tsukino H, Okegawa T, Nutahara K
Hum Cell. 2008; 21(1):1-6.
PMID: 18190394
DOI: 10.1111/j.1749-0774.2007.00042.x.
Circulating colony stimulating factor-1 and breast cancer risk.
Tamimi R, Brugge J, Freedman M, Miron A, Iglehart J, Colditz G
Cancer Res. 2008; 68(1):18-21.
PMID: 18172291
PMC: 2821592.
DOI: 10.1158/0008-5472.CAN-07-3234.
